Publications by authors named "Kumar Perampaladas"

Claim this Profile
N
NICE guidance on vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma.
Kumar Perampaladas, Nicola Hay, Fiona Rinaldi, Janet Robertson, Jane Adam

Lancet Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosiglitazone causes endothelial dysfunction in humans.
Kumar Perampaladas, Tommaso Gori, John D Parker

J Cardiovasc Pharmacol Ther· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raising the bar for market authorisation of new drugs.
Huseyin Naci, Jonathan Cylus, Sotiris Vandoros, Azusa Sato, Kumar Perampaladas

BMJ· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and meta-analysis of the effect of warming local anesthetics on injection pain.
Mary-Ellen Hogan, Sondra vanderVaart, Kumar Perampaladas, Márcio Machado, Thomas R Einarson

Ann Emerg Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indian vaccine innovation: the case of Shantha Biotechnics.
Justin Chakma, Hassan Masum, Kumar Perampaladas, Jennifer Heys, Peter A Singer

Global Health· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of rosiglitazone on nitric oxide bioavailability and endothelial function.
Kumar Perampaladas, John D Parker, Tommaso Gori

Clin Hemorheol Microcirc· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan.
Kumar Perampaladas, Hassan Masum, Andrew Kapoor, Ronak Shah, Abdallah S Daar

BMC Int Health Hum Rights· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case study: India's billion dollar biotech.
Justin Chakma, Hassan Masum, Kumar Perampaladas, Jennifer Heys, Peter A Singer

Nat Biotechnol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis